Ethicists Outline Ways to Improve Risk/Benefit Estimates in New Drug Trials

It's all too familiar: researchers announce the discovery of a new drug that eradicates disease in animals. Then, a few years later, the drug bombs in human trials. Now, two medical ethicists argue that this pattern of boom and bust may be related to the way researchers predict outcomes of their work in early stages of drug development.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews